DC
David Michael Clark
Chief People Officer

David Michael Clark insider trades: Amicus Therapeutics (FOLD) stock sales

Chief People Officer, Amicus Therapeutics Last trade Dec 19, 2025 30 Form 4 filings
$904K
Sold, last 12 months
3 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2020
1
Company
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where David reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 19, 2025FOLD↓ Sell$363K
Dec 15, 2025FOLD↓ Sell$282K
Nov 24, 2025FOLD↓ Sell$259K
Nov 4, 2025FOLD↓ Sell$244K
Feb 15, 2024FOLD↓ Sell$62K
Jan 9, 2024FOLD↓ Sell$142K
Jan 18, 2023FOLD↓ Sell$100K
Jan 6, 2023FOLD↓ Sell$255K
Jan 3, 2023FOLD↓ Sell$102K
Aug 5, 2022FOLD↓ Sell$142K
Feb 12, 2020FOLD↓ Sell$78K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other FOLD insiders

Open-market trades in the last 12 months

About David Michael Clark's insider trades

David Michael Clark is Chief People Officer at Amicus Therapeutics (FOLD). Since Feb 12, 2020, David has reported no open-market purchases and 11 sales worth $2.0M on SEC Form 4. In the last 12 months: 3 sales ($904K).

Their filings also include shares withheld for taxes (17 filings), grants and awards (12 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every FOLD insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.